NKMAX CO., Ltd. 182400.KQ Stock
2020 KRW
{{ price }}
0.000000%
{{change_pct}}%
COUNTRY
South Korea
Exchange
KOSDAQ
Market Cap
50.23B KRW
LOW - HIGH [24H]
2020
-
2020 KRW
VOLUME [24H]
0 KRW
{{ volume }}
P/E Ratio
0
Earnings per share
0 KRW
NKMAX CO., Ltd. Price Chart
NKMAX CO., Ltd. 182400.KQ Financial and Trading Overview
| NKMAX CO., Ltd. stock price | 2020 KRW |
| Previous Close | 12970 KRW |
| Open | 12890 KRW |
| Bid | 13040 KRW x 0 |
| Ask | 13120 KRW x 0 |
| Day's Range | 12710 - 13350 KRW |
| 52 Week Range | 9420 - 20450 KRW |
| Volume | 450.68K KRW |
| Avg. Volume | 520.97K KRW |
| Market Cap | 326.23B KRW |
| Beta (5Y Monthly) | 1.173176 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | 0 KRW |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
182400.KQ Valuation Measures
| Enterprise Value | 556.92B KRW |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 27.871649 |
| Price/Book (mrq) | N/A |
| Enterprise Value/Revenue | 47.581 |
| Enterprise Value/EBITDA | -13.215 |
Trading Information
NKMAX CO., Ltd. Stock Price History
| Beta (5Y Monthly) | 1.173176 |
| 52-Week Change | -17.38% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 20450 KRW |
| 52 Week Low | 9420 KRW |
| 50-Day Moving Average | 12230.8 KRW |
| 200-Day Moving Average | 13221.1 KRW |
182400.KQ Share Statistics
| Avg. Volume (3 month) | 520.97K KRW |
| Avg. Daily Volume (10-Days) | 327.44K KRW |
| Shares Outstanding | 24.86M |
| Float | 33.44M |
| Short Ratio | N/A |
| % Held by Insiders | 15.86% |
| % Held by Institutions | 6.47% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | N/A |
| Trailing Annual Dividend Yield | N/A |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | N/A |
| Last Split Factor | 2:1 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2021 |
| Most Recent Quarter (mrq) | September 30, 2022 |
| Next Fiscal Year End | December 31, 2022 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | -438.80% |
| Gross Margin | 60.09% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -16.98% |
| Return on Equity (ttm) | -57.63% |
Income Statement
| Revenue (ttm) | 11.7B KRW |
| Revenue Per Share (ttm) | 302.31 KRW |
| Quarterly Revenue Growth (yoy) | -14.29% |
| Gross Profit (ttm) | 8.06B KRW |
| EBITDA | -42143117312 KRW |
| Net Income Avi to Common (ttm) | -60705144832 KRW |
| Diluted EPS (ttm) | N/A |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 25.18B KRW |
| Total Cash Per Share (mrq) | 633.01 KRW |
| Total Debt (mrq) | 67.78B KRW |
| Total Debt/Equity (mrq) | 71.26 KRW |
| Current Ratio (mrq) | 0.467 |
| Book Value Per Share (mrq) | N/A |
Cash Flow Statement
| Operating Cash Flow (ttm) | -36632526848 KRW |
| Levered Free Cash Flow (ttm) | -19625631744 KRW |
Profile of NKMAX CO., Ltd.
| Country | South Korea |
| State | N/A |
| City | Seongnam-si |
| Address | 172, Dolma-ro |
| ZIP | 13605 |
| Phone | 82 31 8017 8114 |
| Website | https://www.nkmax.com |
| Industry | |
| Sector(s) | |
| Full Time Employees | 133 |
NKMAX CO., Ltd. manufactures and supplies proteins and monoclonal antibodies worldwide. The company provides anti-cancer immunotherapy treatment that activates the immune cells in body to kill the cancer cells; natural killer cell activity test for cancer patients; and health supplements. It also offers NK PUPPY, a test that measures dog's immunity. The company was formerly known as ATGen Co and changed name to NKMAX CO., Ltd. in 2019. NKMAX CO., Ltd. was founded in 2002 and is headquartered in Seongnam, South Korea.
Q&A For NKMAX CO., Ltd. Stock
What is a current 182400.KQ stock price?
NKMAX CO., Ltd. 182400.KQ stock price today per share is 2020 KRW.
How to purchase NKMAX CO., Ltd. stock?
You can buy 182400.KQ shares on the KOSDAQ exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for NKMAX CO., Ltd.?
The stock symbol or ticker of NKMAX CO., Ltd. is 182400.KQ.
How many shares does NKMAX CO., Ltd. have in circulation?
The max supply of NKMAX CO., Ltd. shares is 24.86M.
What is NKMAX CO., Ltd. Price to Earnings Ratio (PE Ratio)?
NKMAX CO., Ltd. PE Ratio is now.
What was NKMAX CO., Ltd. earnings per share over the trailing 12 months (TTM)?
NKMAX CO., Ltd. EPS is 0 KRW over the trailing 12 months.
NKMAX CO., Ltd. 182400.KQ included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| Kosdaq Manufacturing Index KQ12 | 2779.56 KRW 2.1 USD |
-1.27
|
210.65K KRW 159 USD | 2753.96 KRW 2.08 USD | 2788.98 KRW 2.11 USD | — - | 210.65K KRW 159 USD |
| Kosdaq MID300 Index KQ300 | 720.6 KRW 0.54 USD |
-1.89
|
70.17K KRW 53 USD | 716.77 KRW 0.54 USD | 724.74 KRW 0.55 USD | — - | 70.17K KRW 53 USD |
| Kosdaq Pharmaceuticals Index KQ26 | 9230.64 KRW 6.97 USD |
-0.48
|
22.23K KRW 17 USD | 9102.9 KRW 6.87 USD | 9268.21 KRW 7 USD | — - | 22.23K KRW 17 USD |
- {{ link.label }} {{link}}